152 related articles for article (PubMed ID: 16112176)
21. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
22. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
Zhou XH; Xu ST; Song WY; Teng XD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
[TBL] [Abstract][Full Text] [Related]
23. The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity.
Popiela TJ; Rudnicka-Sosin L; Dutsch-Wicherek M; Klimek M; Basta P; Galazka K; Wicherek L
Neuro Endocrinol Lett; 2006 Dec; 27(6):786-94. PubMed ID: 17187007
[TBL] [Abstract][Full Text] [Related]
24. Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma.
Li J; Jia H; Xie L; Wang X; He H; Lin Y; Hu L
Gynecol Oncol; 2009 Jul; 114(1):89-93. PubMed ID: 19359031
[TBL] [Abstract][Full Text] [Related]
25. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression.
Kim SH; Cho NH; Kim K; Lee JS; Koo BS; Kim JH; Chang JH; Choi EC
J Surg Oncol; 2006 Mar; 93(4):330-7. PubMed ID: 16496371
[TBL] [Abstract][Full Text] [Related]
26. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer.
Kanao H; Enomoto T; Kimura T; Fujita M; Nakashima R; Ueda Y; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Tanigami A; Yoshino K; Murata Y
Cancer Res; 2005 Oct; 65(19):8640-5. PubMed ID: 16204031
[TBL] [Abstract][Full Text] [Related]
28. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
[TBL] [Abstract][Full Text] [Related]
29. Galectin 1 expression is associated with tumor invasion and metastasis in stage IB to IIA cervical cancer.
Kim HJ; Do IG; Jeon HK; Cho YJ; Park YA; Choi JJ; Sung CO; Lee YY; Choi CH; Kim TJ; Kim BG; Lee JW; Bae DS
Hum Pathol; 2013 Jan; 44(1):62-8. PubMed ID: 22939954
[TBL] [Abstract][Full Text] [Related]
30. Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers.
Sakaguchi H; Fujimoto J; Hong BL; Tamaya T
Cancer Lett; 2007 Mar; 247(1):98-102. PubMed ID: 16675104
[TBL] [Abstract][Full Text] [Related]
31. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
32. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
33. A clinical and immunohistochemical study on gastrointestinal mesenchymal tumor (GIMT): RCAS1 as a predictor for recurrence of GIMT.
Naito A; Narikiyo M; Yamada Y; Ueno M; Kamada K; Hachisuka T; Yoriki R; Mizuno T; Nakajima Y
Oncol Rep; 2005 Nov; 14(5):1127-32. PubMed ID: 16211275
[TBL] [Abstract][Full Text] [Related]
34. Expression of RCAS1 and its function in human squamous cell carcinoma of the oral cavity.
Fukuda M; Tanaka A; Hamao A; Suzuki S; Kusama K; Sakashita H
Oncol Rep; 2004 Aug; 12(2):259-67. PubMed ID: 15254686
[TBL] [Abstract][Full Text] [Related]
35. Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia.
Leo C; Richter C; Horn LC; Schütz A; Pilch H; Höckel M
Gynecol Oncol; 2005 May; 97(2):602-6. PubMed ID: 15863166
[TBL] [Abstract][Full Text] [Related]
36. Abnormal fragile histidine triad (Fhit) expression in invasive cervical adenocarcinoma: association with tumor aggressiveness.
Yoon SO
Hum Pathol; 2007 Feb; 38(2):326-31. PubMed ID: 17137614
[TBL] [Abstract][Full Text] [Related]
37. High expression of human nonmetastatic clone 23 type 1 in cancer of uterine cervix and its association with poor cell differentiation and worse overall survival.
Hsu CG; Lin LY; Ko JL; Yang SF; Chang H; Lin CY; Tsai HT; Chen SC; Chen SC; Wang PH
J Surg Oncol; 2008 Nov; 98(6):448-56. PubMed ID: 18668641
[TBL] [Abstract][Full Text] [Related]
38. Versican expression in human cervical cancer.
Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Nakamura K; Hongo A; Hiramatsu Y
Eur J Cancer; 2007 Jun; 43(9):1460-6. PubMed ID: 17446061
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of RCAS1 as a biomarker of ovarian cancer.
Sonoda K; Miyamoto S; Yotsumoto F; Yagi H; Nakashima M; Watanabe T; Nakano H
Oncol Rep; 2007 Mar; 17(3):623-8. PubMed ID: 17273743
[TBL] [Abstract][Full Text] [Related]
40. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix.
Kaku T; Sonoda K; Kamura T; Hirakawa T; Sakai K; Amada S; Ogawa S; Kobayashi H; Nakashima M; Watanabe T; Nakano H
Clin Cancer Res; 1999 Jun; 5(6):1449-53. PubMed ID: 10389931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]